Nous ne pouvons afficher que des informations limitées pour ce cabinet. Nous affichons des informations plus complètes pour les cabinets suivants :
Morrison Foerster 's team demonstrates notable strength in life sciences and high tech patents, with a recent focus on semiconductor and emerging medicine cases. The department has a geographically diverse leadership team. In Washington DC, Mark Whitaker, with experience in all key litigation venues, focuses on semiconductors, optical technologies, chemicals and database analytics. Austin-based Brian Nash is a specialist in complex patent litigation, with a particular focus on disputes in the Eastern and Western Districts of Texas. Rounding out the leadership are Bita Rahebi, based in Los Angeles, and Tim Saulsbury, based in San Francisco; both Rahebi and Saulsbury are key first-chair patent litigators for leading technology companies. Other trusted counsellors include Richard Hung, recognized as a brilliant strategist, and Daralyn Durie, who is highly sought after by both plaintiffs and defendants for her success in IP trials. Both Hung and Durie are located in San Francisco.
L’éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘Morrison Foerster boasts one of the strongest patent enforcement litigation practices. Having relied on MoFo for various IP litigations over the past 15 years, I would recommend them without reservation.’
‘Richard Hung: A brilliant strategist with strong business acumen. Richard not only advises companies on litigation strategies but also guides them through complex competitive landscapes to position his clients for success.'
Clients clés
- Aptiv PLC
- Arbutus Biopharma Corp.
Points forts
- Represented Avadel Pharmaceuticals in a patent infringement trial brought by Jazz Pharmaceuticals relating to an effective treatment for narcolepsy.
- Retained by Neogenomics in a matter alleging infringement on patents related to cell-free DNA testing technologies, crucial for non-invasive cancer testing and monitoring.